ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN)

CUSIP: 00654J107

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / SPONSORED ADS
Total 13F shares
473,916
Share change
+131,811
Total reported value
$379,000
Price per share
$0.80
Number of holders
8
Value change
+$93,800
Number of buys
6
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 00654J107?
CUSIP 00654J107 identifies ADXN - ADDEX THERAPEUTICS LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN) as of Q3 2022

As of 30 Sep 2022, ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 473,916 shares. The largest 8 holders included ARMISTICE CAPITAL, LLC, New Leaf Venture Partners, L.L.C., RENAISSANCE TECHNOLOGIES LLC, FNY Investment Advisers, LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, and UBS Group AG. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.